0.00Open0.00Pre Close0 Volume0 Open Interest17.50Strike Price0.00Turnover0.00%IV-101.27%PremiumMay 16, 2025Expiry Date8.81Intrinsic Value100Multiplier12DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma0.99Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Avadel Pharmaceuticals Stock Discussion
Latest LUMRYZ Data Shows Surging Growth: Avadel Eyes Billion-Dollar Market
LUMRYZ Sales Surge 158% as Avadel Pharmaceuticals Eyes Cash Flow Positive 2025
AVDL fell 25.2% to $8 shortly before 5 p.m. ET after the company announced that Q4 revenues will come in at $50 million – below the $52.7 million that analysts had reportedly expected.
The company like...
yeah, cluster buys drew my attention too
– Findings published in Brain Sciences showed missed doses and potential for injury when waking to take a second dose among the key challen...
🎃⚡️🎃
📊⚡️📊
No comment yet